MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-MH-19-0051126
Wellthy Therapeutics Private Limited - internet in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹6.84 Cr
▲ 96% YoY
Net loss · FY 2025
₹88.37 Lakh
Net margin -12.9%
EBITDA · FY 2025
-₹49.48 Lakh
EBITDA margin -7.2%
Authorised capital
₹7.2 Cr
Registered with MCA
Paid-up capital
₹5.99 Cr
Issued & subscribed
Company age
11 yrs
Est. 2015
Employees · EPFO
23
Provident fund records
Directors on board
3
As per MCA filings
About Wellthy Therapeutics Private Limited
Data last updated:
Wellthy Therapeutics Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the online healthcare services segment of the internet and digital services sector. It was incorporated on 02 December 2015 and has been in existence for over 11 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U93030MH2015PTC270628. Its GSTIN is 27AABCW7410J1Z8 (Maharashtra). The company holds 3 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹7.2 Cr and a paid-up capital of ₹5.99 Cr. It is led by directors including Abhishek Nikhil Shah and Prayat Aasit Shah.
Its last annual general meeting (AGM) was held on 23 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 20 Nagin Mahal 5th Floor 82 Veer Nariman Road Churchgate, Mumbai, Maharashtra, India – 400020.
As per the financials filed for FY 2025, the company reported a revenue of ₹6.84 Cr, a growth of 96% compared to the previous year. For the same year it recorded a net loss of ₹88.37 Lakh (net margin -12.9%) and EBITDA of -₹49.48 Lakh (EBITDA margin -7.2%). Revenue has grown at a compounded annual rate (CAGR) of 18% over three years and 16% over five years.
The company has about 23 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Wellthy Therapeutics. The company has 9 deals on record (5 funding rounds, 2 secondary share transfers, 1 rights issue), with disclosed funding of ₹77.58 Cr; the latest was in November 2023. The company has 11 MSME Form 1 returns on record between 2019 and 2024, listing 138 overdue payments to 15 micro and small suppliers.
Wellthy Therapeutics Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-19-0051126). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website wellthytherapeutics.com.
Company details
CIN U93030MH2015PTC270628
Registration Number 270628
Incorporation Date 02 December 2015
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 23 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-MH-19-0051126
Recognitions & Rankings of Wellthy Therapeutics
Contact details
Wellthy Therapeutics Private Limited's registered office is in Mumbai, Maharashtra. Its website is wellthytherapeutics.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Apps
- Registered Address20 Nagin Mahal 5th Floor 82 Veer Nariman Road Churchgate, Mumbai, Maharashtra, India – 400020
- IndustryInternet, Online Healthcare Services
To see the full contact details of Wellthy Therapeutics Private Limited, buy the company report.
Comprehensive company report
Wellthy Therapeutics Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Wellthy Therapeutics operates one associated brand: Wellthy Therapeutics. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Health monitoring app is provided for chronic patients and providers. | wellthytherapeutics.com |
Business activity
The main business activity of Wellthy Therapeutics is hospital and medical care. In detail, this covers other hospital and medical care activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q6 | Other Hospital and Medical Care Activities |
To see the full business activity and turnover split of Wellthy Therapeutics Private Limited, buy the company report.
Financials of Wellthy Therapeutics Private Limited
FY 2025 filings availableWellthy Therapeutics Private Limited reported revenue of ₹6.84 Cr (up 96% YoY) for FY 2025.
Revenue · FY 2025
₹6.84 Cr ▲ 96%
Net loss · FY 2025
₹88.37 Lakh margin -12.9%
EBITDA · FY 2025
-₹49.48 Lakh margin -7.2%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 96%
3 years · compounded
▲ 18%
5 years · compounded
▲ 16%
EBITDA CAGR growth
1 year
▲ 97%
3 years · compounded
▲ 66%
5 years · compounded
▲ 49%
Revenue has grown at a compounded annual rate (CAGR) of 16% over five years, including 96% growth in the latest year. EBITDA rose 97% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹49.48 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹88.37 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -7.2% | ||||
| Net Profit Margin | -12.9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Wellthy Therapeutics Private Limited, buy the company report.
Board of directors of Wellthy Therapeutics Private Limited
Wellthy Therapeutics has 3 current directors and 6 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Abhishek Nikhil Shah Also directs: Ark-Shah Partners LLP, Marvel Drugs Pvt Ltd | Director | 02 Dec 2015 | 10 Years 11 Months | Current |
| Amit Chhajer | Nominee Director | 28 Jun 2024 | 2 Years 4 Months | Current |
| Prayat Aasit Shah Also directs: Prayat & Krisha LLP | Director | 26 Apr 2024 | 2 Years 6 Months | Current |
Auditor
Wellthy Therapeutics Private Limited is audited by P C GHADIALI AND CO LLP for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| P C GHADIALI AND CO LLP | FY 2023 | 103132W |
Shareholding
The shareholding of Wellthy Therapeutics Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Wellthy Therapeutics Private Limited, buy the company report.
Deals & funding
Wellthy Therapeutics Private Limited has 9 deals on record (5 funding rounds, 2 secondary share transfers, 1 rights issue), with disclosed funding of ₹77.58 Cr; the latest was in November 2023.
Total deals
9
Funding rounds
5
Secondary share transfers
2
Rights issue
1
Acquisition
1
Disclosed funding
₹77.58 Cr
Deals on record (5 of 9)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Nov 2023 | Funding round | ₹13.75 Cr | Investors: Beyond Next Ventures, growX ventures, Saama Capital |
| Apr 2022 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Apr 2021 | Funding round | ₹60.7 Lakh | Investors: Bayer Ag |
| Apr 2020 | Funding round · Pre-Series A | ₹32.1 Cr | Investors: Saama Capital, an individual |
| Mar 2019 | Funding round · Seed | ₹17.5 Cr | Investors: Goldencross Pharma Limited , growX ventures, MEMG Family Office |
To see the full deal history of Wellthy Therapeutics Private Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
No court or tribunal cases involving Wellthy Therapeutics Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
Wellthy Therapeutics Private Limited has 11 MSME Form 1 returns on record between 2019 and 2024, listing 138 overdue payments to 15 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 15)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Expedient Healthcare Marketing Private Limited | |||
| Clevertap Private Limited | |||
| Redcliffe Lifetech Private Limited | |||
| Hja & Associates LLP | |||
| Health Care at Home India Private Limited |
To see the full MSME payment records of Wellthy Therapeutics Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Wellthy Therapeutics Private Limited has a workforce of 23 employees on its EPFO records as of May 2026, across 1 active EPFO establishment.
Employee count
23
Active EPFO establishments
1
Employee growth
-8%
Headcount by financial year
| Financial year | Employees (EPFO) |
|---|---|
| FY 2026-27 | 23 |
| FY 2025-26 | |
| FY 2024-25 | |
| FY 2023-24 | |
| FY 2022-23 | |
| FY 2021-22 | |
| FY 2020-21 | |
| FY 2019-20 | |
| FY 2018-19 | |
| FY 2017-18 |
To see the full employee and EPFO history of Wellthy Therapeutics Private Limited, buy the company report.
GST
Wellthy Therapeutics has 3 GST registrations: 1 active and 2 cancelled or inactive.
Total GSTINs
3
Active
1
Cancelled / inactive
2
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AABCW7410J1Z8 | Maharashtra | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Wellthy Therapeutics Private Limited, buy the company report.
Recent activity
Wellthy Therapeutics Private Limited has 15 board changes on record since 2015: 9 appointments and 6 cessations. The latest: Mahdi Attya ceased to be Nominee Director on 24 Jan 2025.
AGM
Wellthy Therapeutics Private Limited last Annual general meeting of members was held on 23 Sep 2025 as per latest MCA records.
Filing
Wellthy Therapeutics Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai.
Ceased
Mahdi Attya ceased to be Nominee Director.
Appointed
Amit Chhajer was appointed as Nominee Director.
Appointed
Mahdi Attya was appointed as Nominee Director.
Appointed
Prayat Aasit Shah was appointed as Director.
Ceased
Siddharth Dhondiyal ceased to be Nominee Director.
Ceased
Sneha Shah ceased to be Whole-Time Director.
Ceased
Suresh Shanmugham ceased to be Nominee Director.
Ceased
Jasdeep Singh ceased to be Nominee Director.
Appointed
Jasdeep Singh was appointed as Nominee Director.
Ceased
Kunal Anil Khanna ceased to be Nominee Director.
6 earlier events are in the company report.
News
Frequently asked questions
Wellthy Therapeutics is an active private limited company based in Mumbai, Maharashtra, India. The company works in online healthcare services, within the internet industry. It was incorporated on 02 December 2015 (11+ years old) and is registered under CIN U93030MH2015PTC270628.
Wellthy Therapeutics has 3 current directors:
- Abhishek Nikhil Shah - Director
- Amit Chhajer - Nominee Director
- Prayat Aasit Shah - Director
The latest financial statements of Wellthy Therapeutics on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 23 September 2025. Year-wise statements from FY 2016 are in the company report.
The GSTIN of Wellthy Therapeutics is 27AABCW7410J1Z8, registered in Maharashtra. The company has 3 GST registrations in all, of which 1 is active and 2 are cancelled or inactive.
The CIN (Corporate Identification Number) of Wellthy Therapeutics is U93030MH2015PTC270628. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Wellthy Therapeutics was incorporated on 02 December 2015, making it 11+ years old. It is registered with the Registrar of Companies, Mumbai.
Wellthy Therapeutics has 9 deals on record (5 funding rounds, 2 secondary share transfers, 1 rights issue), with disclosed funding of ₹77.58 Cr; the latest was in November 2023.
Mahdi Attya ceased to be Nominee Director on 24 Jan 2025. Amit Chhajer was appointed as Nominee Director on 28 Jun 2024. Mahdi Attya was appointed as Nominee Director on 28 Jun 2024. Wellthy Therapeutics has 15 board changes on record in total.
Yes, Wellthy Therapeutics is registered as a micro enterprise under Udyam registration (number: UDYAM-MH-19-0051126).
Wellthy Therapeutics has 11 MSME Form 1 returns on record between 2019 and 2024, listing 138 overdue payments to 15 micro and small suppliers. The latest return was filed on 22 Apr 2024.
Wellthy Therapeutics can be reached through the website wellthytherapeutics.com. Its registered office is in Mumbai, Maharashtra, India.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages